Your browser doesn't support javascript.
loading
Newcastle disease virus co-expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy.
Xu, Xiaojing; Sun, Qing; Mei, Yu; Liu, Yonghao; Zhao, Lixiang.
Afiliação
  • Xu X; College of Basic Medicine and Biological Sciences, Medical Department, Soochow University, Suzhou, China.
  • Sun Q; Laboratory of Animal Infectious Diseases, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
  • Mei Y; Virus Research Unit, Department of Microbiology and Immunology, School of Medicine, University of Otago, Dunedin, New Zealand.
  • Liu Y; Immunology Programme, Life Sciences Institute and Department of Microbiology and Immunology, National University of Singapore, Singapore City, Singapore.
  • Zhao L; Institute of Blood and Marrow Transplantation, Department of Hematology, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Cancer Sci ; 109(2): 279-288, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29224228
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Vírus da Doença de Newcastle / Interleucina-7 / Interleucina-15 Limite: Animals Idioma: En Revista: Cancer Sci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Vírus da Doença de Newcastle / Interleucina-7 / Interleucina-15 Limite: Animals Idioma: En Revista: Cancer Sci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China